期刊文献+

硫酸吗啡控释片治疗中重度癌性疼痛的临床分析 被引量:7

Clinical analysis of morphine sulfate controlled-released tablet in treating moderate-severe cancer pain
下载PDF
导出
摘要 目的:分析硫酸吗啡控释片治疗中重度癌性疼痛的疗效和不良反应。方法:采用硫酸吗啡控释片治疗64例中重度癌痛患者,初始剂量为20~60mg/d,根据疼痛缓解程度进行剂量调整。结果:硫酸吗啡控释片的平均初始剂量为47.5mg/d,平均最大剂量为91.4mg/d,平均维持剂量为85.8mg/d,平均用药天数为26.5d。服药前患者疼痛强度为7.27±1.29,服药7d后疼痛强度为1.61±1.31,总有效率为90.6%,显效率为75.0%。主要毒副反应为便秘(46.9%),其次是恶心(20.3%)、头昏(12.5%)。结论:硫酸吗啡控释片治疗中重度癌痛疗效确切,不良反应可耐受,是目前控制中重度癌痛的理想药物之一。 Objective: To analyze the efficacy and toxicities of morphine sulfate controlled-released tablet in treating moderate-severe cancer pain. Methods: Sixty four patients with moderate-severe cancer pain were treated with morphine sulfate controlled-released tablet. The daily initial dosage of morphine sulfate controlled -released tablet started from 20 mg to 60 mg, the dosage was adjusted according to the pain relief degree. Results: The mean daily initial dosage, maximum dosage and maintenance dosage were 47.5 mg/d, 91.4 mg/d and 85.8 mg/d respectively, the mean time of taking tablet was 26.5 days. The pain intensity was 7.27±1.29 before treatment and 1.61±1.31 after treatment. The total response rate was 90.6%, significant response rate was 75.0%. The main toxicities were constipation (46.9%), nausea (20.3%) and dizziness (12.5%). Conclusion: Morphine sulfate controlled-released tablet is effective, convenient and tolerable in treating moderate-severe cancer pain. It is one of the ideal medicines in controlling moderate-severe cancer pain.
出处 《中国当代医药》 2012年第2期62-63,共2页 China Modern Medicine
关键词 硫酸吗啡控解片 癌性疼痛 疗效 副反应 Morphine sulfate controlled-released tablet Cancer pain Efficacy Toxicity
  • 相关文献

参考文献8

二级参考文献29

共引文献42

同被引文献54

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部